Trial intelligence / Profile preview

OPC-12759 in dry eye

NCT00885079Phase 3Completed

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
May 2009
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of rebamipide ophthalmic solution in dry eye syndrome (DED), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started May 2009; status: completed.

02

Drugs

rebamipide ophthalmic solution
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT00885079.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00885079.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call